The US pharmaceutical giant Moderna had made an announcement that it would charge governments between $25 and $37 per dose for its COVID-19 vaccine per candidate. Few hours later, Russian drugmaker Sputnik V claimed that its vaccine would be cheaper than those of Pfizer and Moderna.
"Translating pharma lingo: the announced price of Pfizer of $19.50 and Moderna of $25-$37 per dose actually means their price of $39 and $50-$74 per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower," Sputnik V tweeted on November 22.
While speaking with the German weekly Welt am Sonntag (WamS), Moderna CEO Stephane Bancel had said their COVID-19 vaccine would cost the same as a flu shot which is between $10-$50. The earlier announcement by Moderna, the company had claimed that its experimental vaccine is 94.5% effective, which is based on the interim data from the last-clinical trial. With this, Moderna has become the second developer after Pfizer and its partner BioNTech to report results that far exceeded expectations.
US approves this Regeneron antibody treatment
